EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Tuesday 3rd June 2014
Harnessing the immense therapeutic and research potential of stem cells requires extensive quality control to ensure the identity, quality, and safety of the cell. Stem cells of different origin and their capability to differentiate towards a specific phenotype as well as tissue engineered constructs are dependent of all kinds of bioprocesses including cultivation media, biomechanical conditions and purification techniques. All topics dealing with the optimization and analysis of processes leading to defined in vitro cultivated cell lines and engineered tissues - with a special focus on bioreactors - will be discussed in this session. This event has CPD accreditation.
To view the pdf agenda please click on http://lifescienceevents.com/wp-content/uploads/3rdJuneStemBiop2014.pdf
Meeting Chair: Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland
Who Should Attend: All those interested in the use of stem cells for tissue engineered constructs should find this meeting extremely valuable.
The deadline for abstract submissions for oral presentation is March 10th 2014.Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:www.euroscicon.com/AbstractsForOralAndPosterPresentation.pdf Keywords: Clinical Trial Partnerships, stem cells, banking,manufacturing,scale-up,GMP, regenerative,IPS, ATMPs, somatic, stem cells, constructs, human embryonic stem cells, clinical grade, cGMP, macular degeneration, retinal pigment epithelium, RPE, AMD, multiple sclerosis, neurodegeneration,cell therapy, clinician-scientist, stem cell research, translation, career path, Stem Cells, Embryonic, clinical application, Manufacture, Cell Therapies, Process,umbilical cord; cord blood; mesenchymal; biobanking; cell therapy, Stem cell, dynamic culture, differentiation, biomechanics, bioreactor, Biochemical Engineering; Bioreactors; Bone Regeneration; Cultured Meat; Liver Toxicity Mode
|
|
|
Invited Speakers:
|
|
Talks include
Proliferation of ASC-derived endothelial cells in a 3D electrospun mesh: Impact of bone-biomimetic nanocomposite and co-culture with ASC-derived osteoblasts. Dr Johanna Buschmann, Head of Research Laboratories, University Hospital Zurich, Plastic Surgery, Switzerland
Bioreactors for tissue engineering
Dr Marianne Ellis, University of Bath, UK
Development of scalable microcarrier-based tissue engineering Dr Ivan Wall, Lecturer in Regenerative Medicine Bioprocessing, University College London, UK
Immune Regulation by Mesenchymal Stromal Cells from Umbilical Cord Dr John Girdlestone, NHS Blood and Transplant, UK
Additional confirmed speakers
Professor Athanasios Mantalaris, Imperial College London, UKDr Farlan Veraitch, Department of Biochemical Engineering, University College London, UK
|
|